Grading des tumeurs : Questions médicales fréquentes
Nom anglais: Neoplasm Grading
Descriptor UI:D060787
Tree Number:E01.789.612
Termes MeSH sélectionnés :
Neural Networks, Computer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Grading des tumeurs : Questions médicales les plus fréquentes",
"headline": "Grading des tumeurs : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Grading des tumeurs : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-31",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Grading des tumeurs"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pronostic",
"url": "https://questionsmedicales.fr/mesh/D011379",
"about": {
"@type": "MedicalCondition",
"name": "Pronostic",
"code": {
"@type": "MedicalCode",
"code": "D011379",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.789"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Grading des tumeurs",
"alternateName": "Neoplasm Grading",
"code": {
"@type": "MedicalCode",
"code": "D060787",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Halfdan Sorbye",
"url": "https://questionsmedicales.fr/author/Halfdan%20Sorbye",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, Haukeland University Hospital, Bergen, Norway."
}
},
{
"@type": "Person",
"name": "Aurel Perren",
"url": "https://questionsmedicales.fr/author/Aurel%20Perren",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University of Bern, Bern, Switzerland."
}
},
{
"@type": "Person",
"name": "Anne Couvelard",
"url": "https://questionsmedicales.fr/author/Anne%20Couvelard",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Université de Paris, Bichat Hospital, AP-HP, Paris, France."
}
},
{
"@type": "Person",
"name": "Geir Olav Hjortland",
"url": "https://questionsmedicales.fr/author/Geir%20Olav%20Hjortland",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, Oslo University Hospital, Oslo, Norway."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cell Recognition Using BP Neural Network Edge Computing.",
"datePublished": "2022-07-12",
"url": "https://questionsmedicales.fr/article/35935314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/7355233"
}
},
{
"@type": "ScholarlyArticle",
"name": "Decoupled neural network training with re-computation and weight prediction.",
"datePublished": "2023-02-23",
"url": "https://questionsmedicales.fr/article/36821537",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0276427"
}
},
{
"@type": "ScholarlyArticle",
"name": "Energy-efficiency computing of up and down transitions in a neural network.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36722729",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1152/jn.00453.2022"
}
},
{
"@type": "ScholarlyArticle",
"name": "A computational approach to drug repurposing using graph neural networks.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36228466",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.compbiomed.2022.105992"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deep neural networks are not a single hypothesis but a language for expressing computational hypotheses.",
"datePublished": "2023-12-06",
"url": "https://questionsmedicales.fr/article/38054329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S0140525X23001553"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Diagnostic",
"item": "https://questionsmedicales.fr/mesh/D003933"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pronostic",
"item": "https://questionsmedicales.fr/mesh/D011379"
},
{
"@type": "ListItem",
"position": 4,
"name": "Grading des tumeurs",
"item": "https://questionsmedicales.fr/mesh/D060787"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Grading des tumeurs - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Grading des tumeurs",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Grading des tumeurs",
"description": "Comment le grading des tumeurs est-il déterminé ?\nQuels tests sont utilisés pour le grading ?\nQu'est-ce que le grade histologique ?\nLe grading est-il le même pour tous les types de tumeurs ?\nQuelle est l'importance du grading dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D060787?mesh_terms=Neural+Networks,+Computer&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Grading des tumeurs",
"description": "Quels symptômes peuvent indiquer un grading élevé ?\nLe grading influence-t-il les symptômes ?\nLes symptômes varient-ils selon le type de tumeur ?\nComment reconnaître une tumeur agressive ?\nLes symptômes sont-ils toujours présents avec un grading élevé ?",
"url": "https://questionsmedicales.fr/mesh/D060787?mesh_terms=Neural+Networks,+Computer&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Grading des tumeurs",
"description": "Peut-on prévenir les tumeurs à grade élevé ?\nLes dépistages aident-ils à prévenir le grading élevé ?\nQuels facteurs de risque sont évitables ?\nL'alimentation influence-t-elle le risque de tumeurs ?\nLe dépistage précoce est-il efficace ?",
"url": "https://questionsmedicales.fr/mesh/D060787?mesh_terms=Neural+Networks,+Computer&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Grading des tumeurs",
"description": "Comment le grading influence-t-il le traitement ?\nLe grading détermine-t-il le type de chirurgie ?\nLes traitements varient-ils selon le grade ?\nLe suivi est-il différent selon le grading ?\nQuels traitements sont courants pour les tumeurs à grade élevé ?",
"url": "https://questionsmedicales.fr/mesh/D060787?mesh_terms=Neural+Networks,+Computer&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Grading des tumeurs",
"description": "Quelles complications peuvent survenir avec un grading élevé ?\nLe grading affecte-t-il le pronostic ?\nLes complications sont-elles liées au traitement ?\nComment gérer les complications liées au grading ?\nLes complications varient-elles selon le type de tumeur ?",
"url": "https://questionsmedicales.fr/mesh/D060787?mesh_terms=Neural+Networks,+Computer&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Grading des tumeurs",
"description": "Quels sont les principaux facteurs de risque de tumeurs ?\nL'hérédité joue-t-elle un rôle dans le grading ?\nLe mode de vie influence-t-il le risque de tumeurs ?\nLes infections peuvent-elles affecter le grading ?\nL'âge est-il un facteur de risque pour le grading ?",
"url": "https://questionsmedicales.fr/mesh/D060787?mesh_terms=Neural+Networks,+Computer&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le grading des tumeurs est-il déterminé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est basé sur l'examen histopathologique des cellules tumorales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le grading ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biopsies et les analyses histologiques sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le grade histologique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une classification des tumeurs selon leur apparence microscopique."
}
},
{
"@type": "Question",
"name": "Le grading est-il le même pour tous les types de tumeurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque type de tumeur a ses propres critères de grading."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du grading dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il aide à prédire le comportement de la tumeur et à orienter le traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un grading élevé ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la douleur, la perte de poids et la fatigue peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le grading influence-t-il les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un grade élevé peut être associé à des symptômes plus graves."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type et de la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une tumeur agressive ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une tumeur agressive peut provoquer des symptômes rapides et sévères."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents avec un grading élevé ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certaines tumeurs peuvent être asymptomatiques malgré un grade élevé."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs à grade élevé ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures de prévention, comme un mode de vie sain, peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages aident-ils à prévenir le grading élevé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent détecter des tumeurs à un stade précoce."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évitables ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'obésité et l'exposition à des agents cancérigènes sont évitables."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de tumeurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut réduire le risque de certains types de tumeurs."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il efficace ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il permet de détecter des tumeurs moins agressives et d'améliorer le pronostic."
}
},
{
"@type": "Question",
"name": "Comment le grading influence-t-il le traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un grading élevé peut nécessiter des traitements plus agressifs comme la chimiothérapie."
}
},
{
"@type": "Question",
"name": "Le grading détermine-t-il le type de chirurgie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un grade élevé peut nécessiter une chirurgie plus extensive."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le grade ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés en fonction du grade et du type de tumeur."
}
},
{
"@type": "Question",
"name": "Le suivi est-il différent selon le grading ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi plus fréquent est souvent requis pour les tumeurs à grade élevé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont courants pour les tumeurs à grade élevé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chimiothérapie, radiothérapie et interventions chirurgicales sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un grading élevé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la métastase et la récidive sont plus fréquentes."
}
},
{
"@type": "Question",
"name": "Le grading affecte-t-il le pronostic ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un grade élevé est souvent associé à un pronostic moins favorable."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles liées au traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être dues aux traitements agressifs des tumeurs."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées au grading ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des soins palliatifs peuvent aider à gérer les complications."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de tumeur ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent différer selon le type et le grade de la tumeur."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de tumeurs ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'alcool, l'obésité et l'exposition à des agents chimiques."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans le grading ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines prédispositions génétiques peuvent influencer le grading des tumeurs."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de tumeurs ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de développer des tumeurs."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter le grading ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le HPV, peuvent augmenter le risque de tumeurs."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour le grading ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de développer des tumeurs augmente avec l'âge."
}
}
]
}
]
}
This exploration is to solve the efficiency and accuracy of cell recognition in biological experiments. Neural network technology is applied to the research of cell image recognition. The cell image r...
To break the three lockings during backpropagation (BP) process for neural network training, multiple decoupled learning methods have been investigated recently. These methods either lead to significa...
Spontaneous periodic up and down transitions of membrane potentials are considered to be a significant spontaneous activity of slow-wave sleep. Previous theoretical studies have shown that stimulation...
Drug repurposing is an approach to identify new medical indications of approved drugs. This work presents a graph neural network drug repurposing model, which we refer to as GDRnet, to efficiently scr...
An ideal vision model accounts for behavior and neurophysiology in both naturalistic conditions and designed lab experiments. Unlike psychological theories, artificial neural networks (ANNs) actually ...
Biologically plausible computational modeling of visual perception has the potential to link high-level visual experiences to their underlying neurons' spiking dynamic. In this work, we propose a neur...
This paper analyzes the parallel and serial information processing structure of visual system and proposes a visual information processing model with three layers: visual receptor layer, visual inform...
Nowadays, an automated computer-aided diagnosis (CAD) is an approach that plays an important role in the detection of health issues. The main advantages should be in early diagnosis, including high ac...
The methodology is built-in deep data analysis for normalization. In comparison to previous research, the system does not necessitate a feature extraction process that optimizes and reduces system com...
Depending on used data, we have achieved the accuracy, specificity, and sensitivity of 98%, 98%, and 98.5% on the short-term Bonn EEG dataset, and 96.99%, 96.89%, and 97.06% on the long-term CHB-MIT E...
Through the approach to detection, the system offers an optimized solution for seizure diagnosis health problems. The proposed solution should be implemented in all clinical or home environments for d...
Using an attention mechanism based on the convolutional neural networks (CNNs) improves the performance of computer vision tasks by enhancing the representation of the features. The existing attention...
Zygomatic fractures involve complex anatomical structures of the mid-face and the diagnosis can be challenging and labor-consuming. This research aimed to evaluate the performance of an automatic algo...
We designed a cross-sectional retrospective diagnostic trial study. Clinical records and CT scans of patients with zygomatic fractures were reviewed. The sample consisted of two types of patients with...
A total of 379 patients with an average age of 35.43 ± 12.74 years were included in the study. There were 203 nonfracture patients and 176 fracture patients with 220 sites of zygomatic fractures (44 p...
The performance of the algorithm based on CNNs was not statistically different from the gold standard (manual diagnosis) for zygomatic fracture detection in order for the algorithm to be applied clini...